Van ECK Associates Corp Purchases 10,342 Shares of Exponent, Inc. (NASDAQ:EXPO)

Van ECK Associates Corp grew its position in Exponent, Inc. (NASDAQ:EXPOFree Report) by 40.0% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 36,194 shares of the business services provider’s stock after buying an additional 10,342 shares during the period. Van ECK Associates Corp owned 0.07% of Exponent worth $3,876,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Comerica Bank increased its position in Exponent by 8.7% during the 1st quarter. Comerica Bank now owns 231,131 shares of the business services provider’s stock valued at $19,112,000 after buying an additional 18,429 shares in the last quarter. Silvercrest Asset Management Group LLC increased its holdings in shares of Exponent by 6.8% during the first quarter. Silvercrest Asset Management Group LLC now owns 276,500 shares of the business services provider’s stock valued at $22,864,000 after acquiring an additional 17,496 shares in the last quarter. SG Americas Securities LLC raised its position in shares of Exponent by 601.1% in the 1st quarter. SG Americas Securities LLC now owns 12,866 shares of the business services provider’s stock valued at $1,064,000 after purchasing an additional 11,031 shares during the last quarter. Raymond James & Associates boosted its stake in Exponent by 4.1% in the 2nd quarter. Raymond James & Associates now owns 487,035 shares of the business services provider’s stock worth $46,327,000 after purchasing an additional 19,051 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in Exponent by 5.8% during the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after purchasing an additional 291,047 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Exponent news, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the sale, the director now directly owns 5,871 shares in the company, valued at approximately $565,494.72. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, Director Paul R. Johnston sold 14,000 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the sale, the director now directly owns 80,742 shares of the company’s stock, valued at $8,445,613.20. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the transaction, the director now owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.10% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, Truist Financial reaffirmed a “buy” rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.

Read Our Latest Report on Exponent

Exponent Stock Performance

Exponent stock opened at $104.97 on Friday. The business’s 50-day simple moving average is $107.64 and its two-hundred day simple moving average is $101.57. The company has a market cap of $5.33 billion, a PE ratio of 50.71 and a beta of 0.69. Exponent, Inc. has a fifty-two week low of $68.70 and a fifty-two week high of $115.75.

Exponent Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be given a $0.28 dividend. The ex-dividend date is Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a yield of 1.07%. Exponent’s dividend payout ratio is currently 54.11%.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.